Effects of Toxoplasma gondii infection on the function and integrity of human cerebrovascular endothelial cells and the influence of verapamil treatment in vitro

2020 ◽  
Vol 1746 ◽  
pp. 147002 ◽  
Author(s):  
M.S.R. Harun ◽  
Victoria Marsh ◽  
Nashwa A. Elsaied ◽  
Kevin F. Webb ◽  
Hany M. Elsheikha
2020 ◽  
Vol 8 (9) ◽  
pp. 1386
Author(s):  
Alaa T. Al-sandaqchi ◽  
Victoria Marsh ◽  
Huw E. L. Williams ◽  
Carl W. Stevenson ◽  
Hany M. Elsheikha

Toxoplasma gondii (T. gondii), the causative agent of toxoplasmosis, is a frequent cause of brain infection. Despite its known ability to invade the brain, there is still a dire need to better understand the mechanisms by which this parasite interacts with and crosses the blood–brain barrier (BBB). The present study revealed structural and functional changes associated with infection and replication of T. gondii within human brain microvascular endothelial cells (BMECs) in vitro. T. gondii proliferated within the BMECs and disrupted the integrity of the cerebrovascular barrier through diminishing the cellular viability, disruption of the intercellular junctions and increasing permeability of the BMEC monolayer, as well as altering lipid homeostasis. Proton nuclear magnetic resonance (1H NMR)-based metabolomics combined with multivariate data analysis revealed profiles that can be attributed to infection and variations in the amounts of certain metabolites (e.g., amino acids, fatty acids) in the extracts of infected compared to control cells. Notably, treatment with the Ca2+ channel blocker verapamil rescued BMEC barrier integrity and restricted intracellular replication of the tachyzoites regardless of the time of treatment application (i.e., prior to infection, early- and late-infection). This study provides new insights into the structural and functional changes that accompany T. gondii infection of the BMECs, and sheds light upon the ability of verapamil to inhibit the parasite proliferation and to ameliorate the adverse effects caused by T. gondii infection.


2013 ◽  
Vol 27 (S1) ◽  
Author(s):  
Christopher Blom ◽  
Brittany Deller ◽  
Douglas D Fraser ◽  
Claudio Martin ◽  
Bryan Young ◽  
...  

Author(s):  
Laura V. Souza ◽  
Marcos P. O. Almeida ◽  
Neide M. Silva ◽  
Natália C. de Miranda ◽  
Liliane Nebo ◽  
...  

Stroke ◽  
2014 ◽  
Vol 45 (suppl_1) ◽  
Author(s):  
Xuwei Hou ◽  
Zhaohui Hu ◽  
Ningfu Wang

Background: Statin therapy is beneficial for ischemic stroke (IS) partly due to its pro-angiogenic effect. In diabetes patients, the accumulations of advanced glycation end products (AGEs) impair the angiogenic potential of endothelial cells (ECs), comprising collateral circulation in ischemic area. Autophagy affects endothelial function. The effect of statins on EC autophagy remains largely unknown. This study was to: 1.investigate the effect of Statin on the angiogenesis ability of ECs impaired by AGEs; 2. explore the autophagy of ECs in this process. Methods: primary cerebromicrovascular endothelial cells (CMVECs) were isolated from Wistar rats and cultured in medium. CMVECs were treated with AGEs. Subsequently, Simvastatin was added to cells. The angiogenic potential was evaluated by tube formation in vitro. Two autophagy marker, Beclin1 and LC3 protein expression were detected by western blot assay. The autophagosome quantitative analysis was evaluated by GFP-LC3-II assay. Results: AGEs (25mg/L, 50mg/L and 100mg/L) reduced the number of tube like structures in a dose dependant manner, accompanied by dramatically enhanced cellular autophagy level indicated by the increased GFP-LC3-II puncta number/cell and increased Beclin1 and LC3 expressions. Autophagy inhibitor 3-MA reversed the AGEs impaired angiogenic ability of CMVES. Simvastatin administration (10μmol/L) markedly increased the angiogenic potential of CMVES evaluated by tube formation ability, together with decreased Beclin1 and LC3, as well as decreased GFP-LC3-II puncta number/cell. AGEs significantly inhibits the PI3K/Akt/mTOR, while Simvastatin re-activate this pathway. More interestingly, the addition of mTOR inhibitor, rapamycin, which enhance the cellular autophagy, abolished the rescue effect of Simvastatin on the angiogenic potential of CMVECs impaired by AGEs. Conclusion: This study provides evidence that AGEs impair the angiogenesis ability via triggering high level of autophagy of CMVECs. Simvastatin rescue the angiogenic ability of CMVECs by surprising autophagy level via activation of PI3K/Akt/mTOR pathway.


Metallomics ◽  
2018 ◽  
Vol 10 (10) ◽  
pp. 1401-1414 ◽  
Author(s):  
Alaa T. Al-sandaqchi ◽  
Chris Brignell ◽  
Joanna F. Collingwood ◽  
Kalotina Geraki ◽  
Evgeny M. Mirkes ◽  
...  

Elemental profiling identifies elements significantly associated with Toxoplasma gondii infection in cerebrovascular endothelial cells.


Sign in / Sign up

Export Citation Format

Share Document